Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double-blind, randomized, placebo-controlled study (RECOVER) - Trenkwalder, Claudia; Kies, Bryan; Rudzinska, Monika; Fine, Jennifer; Nikl, Janos; Honczarenko, Krystyna; Dioszeghy, Peter; Hill, Dennis; Anderson, Tim; Myllyla, Vilho; Kassubek, Jan; Steiger, Malcolm; et al. (Movement disorders, 2011)
Keywords: Adult; Aged; Aged, 80 and over; Biological and medical sciences; Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases; dopamine agonist; Dopamine Agonists - therapeutic use; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Medical sciences; Middle Aged; Motor Activity - drug effects; motor function; Neurology; Parkinson Disease - complications; quality of life; rotigotine; Severity of Illness Index; sleep; Sleep Wake Disorders - drug therapy; Sleep Wake Disorders - etiology; Tetrahydronaphthalenes - therapeutic use; Thiophenes - therapeutic use; transdermal; Treatment Outcome; Nervous system diseases; Morning; Parkinson disease; Cerebral disorder; Quality of life; Sleep; transdermal; Central nervous system disease; Placebo; Dopamine agonist; Double blind study; Rotigotine; Degenerative disease; Sleep wake cycle; motor function; Extrapyramidal syndrome